MedPath

Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female.

Not Applicable
Recruiting
Conditions
Oral Contraceptive Use
Menstrual Cycle
Interventions
Diagnostic Test: Hamstring muscles function assessment
Registration Number
NCT05802277
Lead Sponsor
EZUS-LYON 1
Brief Summary

The goal of this clinical trial is to precise the impact of menstrual cycle and physical activity on the hamstrings muscle function in healthy active women. The main question it aims to answer is : is there a moment of the menstrual cycle when the muscle is better able to recover from a strenuous exercise ? Three appointments will be conducted to evaluate the hamstring muscles at difference moments of the menstrual cycle. Echographic and maximal force production measures will be done.

Researchers will compare these results with a group taking oral contraceptives.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
130
Inclusion Criteria
  • Subject aged between 18 and 35 years.
  • Subjects who practice at least 2 hours of sport per week with a competitive aim.
  • Subject who has not presented any musculo-tendinous pathology to the hamstrings in the last 6 months.
  • Subject with no musculoarticular pathology having a prolonged (more than 2 weeks) interruption of sports activities in the last 2 years.
  • Subject with no muscular pain or pathology currently.
  • Subject with no known cardiac disorders or family history that could present a risk known family history that could present a risk in case of intense physical effort.

physical exertion.

  • Subjects not taking any medication, which in the opinion of the that, in the opinion of the coordinating investigator, may interfere with the evaluation of the study criteria.
  • Subject able and willing to comply with the protocol and agreeing to give written informed consent.
  • Subject affiliated or benefiting from a Social Security plan.

Menstrual cycle group:

  • Subject whose last 3 menstrual cycles are of a regular duration (± 4 days maximum difference between 2 consecutive menstrual cycles).
  • Subject whose last 3 menstrual cycles are of a duration between 24 and 32 days (including milestones).
  • Absence of any contraceptive method likely to modulate the hormonal variations linked to the menstrual cycle.

hormonal variations related to the menstrual cycle, during the duration of the duration of the protocol and during the last 6 months after the participant's inclusion.

the participant. Mechanical contraception such as the diaphragm is permitted.

Oral contraceptive group:

  • Taking oral contraception, 2nd generation monophasic pill estrogen-progestin pill (Optilova®, Optidril®, Leeloo®, Minidril®, Ludeal®, Zikiale®, Lovavulo®, Lovapharm®) for at least 6 months.
Exclusion Criteria
  • Subjects with a medical contraindication to intense physical activity.
  • Subject with a positive pregnancy test result.
  • Subject with a medical or surgical history deemed by the coordinating investigator as being incompatible with the study.
  • Subjects under guardianship.
  • Subjects in a period of exclusion from another study.
  • Decision of the volunteer, whatever the reason.
  • Adverse event or effect affecting the safety of the volunteer in the opinion of the coordinating investigator.
  • Major deviation from the protocol.
  • Illness or injury interfering with the normal course of the protocol.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Oral contraceptive groupHamstring muscles function assessmentWomen taking a second-generation oral contraceptive estrogen-progestogen pill.
Menstrual cycle groupHamstring muscles function assessmentWomen who are not currently taking any form of hormonal contraception and who present a regular menstrual cycle.
Primary Outcome Measures
NameTimeMethod
Hamstring muscles shear wave speedLength of a menstrual cycle (around on 28 day average)

Differences according to menstrual cycle phase in hamstring muscles shear wave speed, as measured by ultrasound elastography

Secondary Outcome Measures
NameTimeMethod
Maximal voluntary force productionLength of a menstrual cycle (around on 28 day average)

Differences according to menstrual cycle phase in maximal voluntary isometric hamstrings force production, as measured by an isokinetic dynamometer

Hamstring muscles thicknessLength of a menstrual cycle (around on 28 day average)

Differences according to menstrual cycle phase in hamstring muscles thickness, as measured by ultrasound echography.

Hamstring muscles length of fasciclesLength of a menstrual cycle (around on 28 day average)

Differences according to menstrual cycle phase in hamstring muscles fascicles' length, as measured by ultrasound echography.

Maximal knee joint range of motionLength of a menstrual cycle (around on 28 day average)

Measure of the volunteer maximal knee range of motion, the maximum being defined by the volunteer as the greatest hip/leg angle reachable without feeling pain. The process is slowly conducted on an isokinetic ergometer by extending the knee joint (2°/s) until the volunteer reaches her maximal range of motion, at which point the movement is stopped and a security is placed.

Hamstring muscles cross sectional areaLength of a menstrual cycle (around on 28 day average)

Differences according to menstrual cycle phase in hamstring muscles cross sectional area, as measured by ultrasound echography.

Hamstring muscles pennation angleLength of a menstrual cycle (around on 28 day average)

Differences according to menstrual cycle phase in hamstring muscles pennation angle, as measured by ultrasound echography.

Hamstring tendons lengthLength of a menstrual cycle (around on 28 day average)

Differences according to menstrual cycle phase in hamstring tendons length, as measured by ultrasound echography.

Trial Locations

Locations (1)

Laboratoire Interuniversitaire de Biologie de la Motricité

🇫🇷

Villeurbanne, Rhône, France

© Copyright 2025. All Rights Reserved by MedPath